James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 45,490 shares at $57.51 ($2.6M) on 2020-01-02, disclosed to the SEC on 2020-01-06.
Open-market sale of $2.6M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.51 | 9,541 | $549K | 20.9% |
| 2 | $57.51 | 9,541 | $549K | 20.9% |
| 3 | $58.08 | 5,347 | $311K | 11.8% |
| 4 | $58.08 | 5,347 | $311K | 11.8% |
| 5 | $59.38 | 365 | $22K | 0.8% |
| 6 | $61.87 | 300 |
| $19K |
| 0.7% |
| 7 | $55.96 | 729 | $41K | 1.6% |
| 8 | $57.21 | 5,250 | $300K | 11.5% |
| 9 | $57.21 | 5,250 | $300K | 11.5% |
| 10 | $58.17 | 1,810 | $105K | 4.0% |
| 11 | $58.17 | 1,810 | $105K | 4.0% |
| 12 | $58.72 | 200 | $12K | 0.4% |
| Total | $57.65 avg | 45,490 | $2.6M | 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-10-13 | $2.5M | — | Filing → |